TransMedics Group, Inc. Cash and Restricted Cash
TransMedics Group, Inc. (TMDX) had Cash and Restricted Cash of $491.11 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $491.11M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $480.18M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $488.87M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $466.67M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $491.11M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $480.18M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $488.87M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $466.67M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $401.07M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $310.64M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $337.15M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $330.59M 10-Q · filed 2025-10-29 |
| 2024-06-30 | $363.25M 10-Q · filed 2025-07-30 |
| 2024-03-31 | $350.72M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $395.31M 10-K · filed 2026-02-24 |
| 2023-09-30 | $427.61M 10-Q · filed 2024-10-29 |
| 2023-06-30 | $582.96M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $196.13M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $201.68M 10-K · filed 2026-02-24 |
| 2022-09-30 | $204.96M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $30.89M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $18.40M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $26.08M 10-K · filed 2025-02-27 |
| 2021-09-30 | $23.00M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $25.81M 10-Q · filed 2022-08-03 |
| 2021-03-31 | $27.23M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $25.08M 10-K · filed 2024-02-27 |
| 2020-09-30 | $21.90M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $51.65M 10-Q · filed 2021-08-06 |
| 2020-03-31 | $25.24M 10-Q · filed 2021-05-07 |
| 2019-12-31 | $20.59M 10-Q · filed 2021-08-06 |
| 2019-12-28 | $20.59M 10-K · filed 2023-02-27 |
| 2019-09-28 | $20.91M 10-Q · filed 2020-11-06 |
| 2019-06-29 | $47.74M 10-Q · filed 2020-08-07 |
| 2019-03-30 | $12.71M 10-Q · filed 2020-05-06 |
| 2018-12-29 | $20.74M 10-K · filed 2021-03-11 |
| 2018-12-28 | $20.74M 10-Q · filed 2020-11-06 |
| 2018-09-29 | $29.39M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $34.94M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $10.30M 10-Q · filed 2019-06-12 |
| 2017-12-30 | $12.44M 10-K · filed 2020-03-17 |
| 2017-12-29 | $12.44M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |